Header Logo

Connection

David Moore to HIV Seropositivity

This is a "connection" page, showing publications David Moore has written about HIV Seropositivity.
Connection Strength

0,898
  1. Felt Age Discrepancy Differs by HIV Serostatus: A Secondary Analysis. J Assoc Nurses AIDS Care. 2020 Sep-Oct; 31(5):587-597.
    View in: PubMed
    Score: 0,598
  2. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS. 2012 Jul; 26(7):388-94.
    View in: PubMed
    Score: 0,085
  3. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):95-9.
    View in: PubMed
    Score: 0,077
  4. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12.
    View in: PubMed
    Score: 0,046
  5. 'People say that we are already dead much as we can still walk': a qualitative investigation of community and couples' understanding of HIV serodiscordance in rural Uganda. BMC Infect Dis. 2016 11 10; 16(1):665.
    View in: PubMed
    Score: 0,029
  6. Efavirenz as a cause of ataxia in children. S Afr Med J. 2015 Nov; 105(11):897-8.
    View in: PubMed
    Score: 0,027
  7. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014; 26(12):1477-81.
    View in: PubMed
    Score: 0,024
  8. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31.
    View in: PubMed
    Score: 0,012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.